NASDAQ:ALT

Altimmune Stock News

Healthcare > Biotechnology

Buy ALT

*Your capital is at risk

$2.92

+0.0500 (+1.74%)

At Close: Jun 04, 2026

Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

06:41am, Wednesday, 10'th Jul 2024

GLP-1 medicines for obesity are all the rage these days. Viking Therapeutics' candidate has the edge in the speed of weight loss.

7 Bullish Stock Picks With the Potential to Turn $5K Into $50K

06:42am, Tuesday, 09'th Jul 2024

Investors looking for opportunities will always be interested in high-potential stocks capable of turning $5K into $50K. Realistically speaking, securing 10x returns is not particularly easy.

The 7 Best Under $10 Stocks to Buy in July 2024

08:00am, Saturday, 06'th Jul 2024

Savvy investors are discovering rewarding opportunities in some of the best stocks under $10 a share. Years ago, I found Advanced Micro Devices (NASDAQ: AMD ) at $10 a share and watched it rocket abov

Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT

12:30pm, Friday, 05'th Jul 2024

NEW YORK, NY / ACCESSWIRE / July 5, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow

Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 5, 2024 - ALT

12:25pm, Friday, 05'th Jul 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT

12:00pm, Friday, 05'th Jul 2024

NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT) and certain officers.

Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT

05:30am, Friday, 05'th Jul 2024

Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT

05:30am, Friday, 05'th Jul 2024

FINAL ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit

05:00am, Friday, 05'th Jul 2024

NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc. (

FINAL ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit!

05:00am, Friday, 05'th Jul 2024

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by